Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,095 USD | +1,14% | -8,63% | -28,65% |
22/03 | Sectorupdate: Gezondheidszorgaandelen stabiel vóór de beursgang vrijdag | MT |
22/03 | Sectorupdate: Gezondheidszorg | MT |
Omzet 2024 * | 41,43 mln. 38,83 mln. | Omzet 2025 * | - | Marktkapitalisatie | 78,61 mln. 73,68 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1 mln. 937K | Nettowinst (verlies) 2025 * | - | EV/omzet 2024 * | 1,9 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
43,7
x | K/w-verhouding 2025 * |
-
| Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 87,03% |
Recentste transcriptie over Eton Pharmaceuticals, Inc.
1 dag | +1,14% | ||
1 week | -8,63% | ||
Lopende maand | -16,67% | ||
1 maand | -11,72% | ||
3 maanden | -24,52% | ||
6 maanden | -17,11% | ||
Lopend jaar | -28,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Sean Brynjelsen
CEO | Chief Executive Officer | 52 | 01-06-17 |
James Gruber
DFI | Director of Finance/CFO | 52 | 11-04-22 |
Lisa M. Wilson
IRC | Investor Relations Contact | 59 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 78 | 01-06-17 | |
Paul Maier
BRD | Director/Board Member | 76 | 14-09-17 |
Norbert Riedel
CHM | Chairman | 66 | 07-09-17 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
19-04-24 | 3,125 | +2,12% | 9 479 |
18-04-24 | 3,06 | -2,55% | 68 832 |
17-04-24 | 3,14 | -1,57% | 94 860 |
16-04-24 | 3,19 | -0,93% | 29 822 |
15-04-24 | 3,22 | -5,85% | 90 153 |
uitgestelde koers Nasdaq, 19 april 2024 om 15:55 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-28,65% | 78,61 mln. | |
+10,08% | 9,12 mld. | |
-15,94% | 4,8 mld. | |
+1,89% | 3,8 mld. | |
+18,47% | 3,72 mld. | |
+25,82% | 2,58 mld. | |
-24,63% | 2,36 mld. | |
-29,37% | 2,11 mld. | |
+2,55% | 1,86 mld. | |
-0,50% | 1,64 mld. |